Literature DB >> 22966389

Usefulness of (18)F-FDG positron emission tomography/computed tomography for the diagnosis of pyothorax-associated lymphoma: A report of three cases.

Yoshiyuki Abe1, Katsumi Tamura, Ikuko Sakata, Jiro Ishida, Isao Fukuba, Rokuro Matsuoka, Seiichiro Shimizu, Hiroshi Murakami, Kikuo Machida.   

Abstract

Pyothorax-associated lymphoma (PAL) is a unique and rare non-Hodgkin's lymphoma developing in the pleural cavity following a long-standing history of chronic pyothorax (CP). The development of F-18 2'-deoxy-2fluoro-D-glucose (FDG) positron emission tomography combined with computed tomography (PET/CT) has contributed to the evaluation of lymphoma staging. However, only a few studies describing FDG-PET/CT findings in PAL have been published. This study reported three cases of PAL; all 3 patients had previously undergone artificial collapse therapy for pulmonary tuberculosis. Both the first case (an 84-year-old male) and second case (an 83-year-old male) complained of abdominal pain. An ultrasound scan revealed a mass shadow in the left chest wall without abnormal findings in the abdomen, and the CT and magnetic resonance imaging scans suggested malignant lymphoma of the left chest. FDG-PET/CT imaging showed extremely intense FDG uptake only in the left pleura and chest wall. Diagnosis was CP in the two patients, showing a high maximum standardized uptake value (SUVmax: early, 14.8 and delayed, 19.4 in the first case; early, 20.8 and delayed, 27.3 in the second case, respectively). Histopathological analysis of the specimens obtained by biopsy of the PET/CT-positive pleural mass showed non-Hodgkin's, diffuse large B cell lymphoma in the two cases. The third case was a 79-year-old male with relapse after right pleuropneumonectomy for PAL (diffuse large B cell lymphoma) 4 years earlier. PET/CT showed intense FDG uptake (SUVmax: early, 19.9 and delayed, 35.7) in the right pleura and chest wall. Diagnosis was CP, suggesting the recurrence of PAL. Furthermore, abnormal intense FDG uptake was noted in the hilar, mediastinal and supraclavicular lymph nodes, as well as in the spleen. In conclusion, FDG-PET/CT imaging is useful in the evaluation of the area of invasion in PAL.

Entities:  

Year:  2010        PMID: 22966389      PMCID: PMC3436407          DOI: 10.3892/ol_00000146

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  14 in total

1.  EBV-associated diffuse large B-cell lymphoma arising in the chest wall with surgical mesh implant.

Authors:  Masakazu Fujimoto; Hironori Haga; Miki Okamoto; Emi Obara; Misa Ishihara; Naomi Mizuta; Koichi Nishimura; Toshiaki Manabe
Journal:  Pathol Int       Date:  2008-10       Impact factor: 2.534

Review 2.  Pyothorax-associated lymphoma.

Authors:  Katsuyuki Aozasa
Journal:  J Clin Exp Hematop       Date:  2006-03

3.  Pyothorax-associated lymphoma: imaging findings.

Authors:  Takuya Ueda; Christe Andreas; Jun Itami; Kunihisa Miyakawa; Hajime Fujimoto; Hisao Ito; Justus E Roos
Journal:  AJR Am J Roentgenol       Date:  2010-01       Impact factor: 3.959

4.  Pyothorax-associated lymphoma: a review of 106 cases.

Authors:  Shin-Ichi Nakatsuka; Masayuki Yao; Yoshihiko Hoshida; Satoru Yamamoto; Keiji Iuchi; Katsuyuki Aozasa
Journal:  J Clin Oncol       Date:  2002-10-15       Impact factor: 44.544

5.  Loss of expression of Epstein-Barr virus nuclear antigen-2 correlates with a poor prognosis in cases of pyothorax-associated lymphoma.

Authors:  Tetsuya Takakuwa; Maria Francisca Ham; Wen-Juan Luo; Shin-ichi Nakatsuka; Masanori Daibata; Katsuyuki Aozasa
Journal:  Int J Cancer       Date:  2006-06-01       Impact factor: 7.396

6.  Usefulness of FDG-PET imaging for the radiotherapy treatment planning of pyothorax-associated lymphoma.

Authors:  Hirofumi Asakura; Taro Togami; Masahiro Mitani; Hitoshi Takashima; Koiku Yokoe; Yuka Yamamoto; Yoshihiro Nishiyama; Toshihide Monden; Yoshihiro Toyama; Motoomi Ohkawa
Journal:  Ann Nucl Med       Date:  2005-12       Impact factor: 2.668

Review 7.  Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears?

Authors:  L Kostakoglu; S J Goldsmith
Journal:  Eur J Nucl Med       Date:  2000-10

8.  Treatment for pyothorax-associated lymphoma.

Authors:  T Aruga; J Itami; K Nakajima; K Shibata; T Nojo; M Aruga; K Inagaki; T Morita; H Ito; T Nomura; A Mikami; K Nemoto; S Yasuda; T Uno; R Hara; K Isobe; N Machida
Journal:  Radiother Oncol       Date:  2000-07       Impact factor: 6.280

9.  (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.

Authors:  Michal Weiler-Sagie; Olga Bushelev; Ron Epelbaum; Eldad J Dann; Nissim Haim; Irit Avivi; Ayelet Ben-Barak; Yehudit Ben-Arie; Rachel Bar-Shalom; Ora Israel
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

10.  Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.

Authors:  P L Zinzani; S Fanti; G Battista; M Tani; P Castellucci; V Stefoni; L Alinari; M Farsad; G Musuraca; A Gabriele; E Marchi; C Nanni; R Canini; N Monetti; M Baccarani
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

View more
  2 in total

1.  A case of early stage lung cancer detected by repeated cancer screening with positron emission tomography.

Authors:  Ikuko Sakata; Yuichi Ozeki; Katsumi Tamura; Jiro Ishida; Shinsuke Aida; Yoshiyuki Abe
Journal:  Oncol Lett       Date:  2011-11-22       Impact factor: 2.967

2.  A case of primary lung cancer lesion demonstrated by F-18 FDG positron emission tomography/computed tomography (PET/CT) one year after the detection of metastatic brain tumor.

Authors:  Yuichi Ozeki; Yoshiyuki Abe; Hideyuki Kita; Katsumi Tamura; Ikuko Sakata; Jiro Ishida; Kikuo Machida
Journal:  Oncol Lett       Date:  2011-05-16       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.